Positive results from a study of ivacaftor (Kalydeco®) in children ages 1 to 2 were announced today.
Dec. 7, 2017
|
2 min read
Two Phase 3 clinical trials of tezacaftor (VX-661) in combination with ivacaftor (Kalydeco®) showed positive results, Vertex Pharmaceuticals announced today.
March 28, 2017
|
4 min read
Update: On February 3, 2017, the Cystic Fibrosis Foundation divested its remaining ownership stake in CF Services Inc., a specialty pharmacy. The pharmacy is now fully owned by Walgreens.
Feb. 3, 2017
|
3 min read